Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



3 Stocks That Blew the Market Away

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

Don't settle for ordinary quarterly reports.

I take a look at three companies that beat market expectations every week, since I believe that it's the biggest factor in a stock beating the market. Leaving Wall Street's pros with stunned expressions can be a good thing. It usually means that the companies have more in the tank than analysts figured. Capital appreciation typically follows.

Let's take a look at a few companies that humbled the prognosticators over the past few trading days.

We can start with Spectrum Pharmaceuticals (Nasdaq: SPPI  ) . The nascent drugmaker posted a quarterly profit of $0.34 a share, more than three times the $0.11 a share that pros were targeting. Spectrum was helped by brisk sales of its Fusilev, a drug used to combat the side effects of chemotherapy. It was a good week for small yet profitable drug upstarts since Neurocrine Biosciences (Nasdaq: NBIX  ) also earned roughly triple what Wall Street was expecting.

Garmin (Nasdaq: GRMN  ) shares rocked to a new 52-week high after a blowout quarter. Analysts figured the GPS giant would earn $0.50 a share after posting net income of $0.70 a share a year earlier. It came through with a profit of $0.71 a share. Strength in fitness, aviation, and outdoor products wasn't enough to grow Garmin's revenue, which declined by 4%, but it is helping wean Garmin off its once flagship GPS gadgetry for drivers.

Finally, we have Sirius XM Radio (Nasdaq: SIRI  ) . The satellite radio giant's profit of $0.02 a share may not seem like much, but that's what happens when you have 6.5 billion shares outstanding. The important takeaway here is that it was twice as much as what Wall Street watchers were projecting. 

It's important to keep watching the companies that surpass expectations. Over time, it will be a lucrative experience for investors as the market rewards the overachievers. That's the kind of surprise that we look for in the Rule Breakers newsletter service. Want in? Check out a 30-day trial subscription.

Either way, come back next Monday to learn about more stocks that blew the market away.

If you want to track these stocks to see if they come out ahead next quarter, add them to MyWatchlist:

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Longtime Fool contributor Rick Munarriz calls them as he sees them. He does not own shares in any of the stocks in this story. Rick is also part of the Rule Breakers newsletter research team, seeking out tomorrow's ultimate growth stocks a day early.

Read/Post Comments (1) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On November 07, 2011, at 9:13 PM, HWY216 wrote:


    Thanks for the mention of SPPI. I have ridden the rollercoaster long this stock for awhile and am grateful to see that it is making progress.

    Am awaiting the 11/20 FDA decision on dropping the Zevalin bioscan. That decision should move the stock one way or another.

    Longer term, 2012 should be telling for their Phase 3 drugs Apaziquone & Belinostat. 4 marketable drugs in the stable should make Spectrum Pharmaceuticals a legitimate player in their industry.

    I wish them all the success in the world!!

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1584764, ~/Articles/ArticleHandler.aspx, 10/24/2016 4:24:57 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,223.03 77.32 0.43%
S&P 500 2,151.33 10.17 0.47%
NASD 5,309.83 52.43 1.00%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/24/2016 4:00 PM
GRMN $48.88 Up +0.28 +0.58%
Garmin CAPS Rating: **
SIRI $4.18 Up +0.03 +0.72%
Sirius XM Radio CAPS Rating: **
SPPI $3.83 Down -0.11 -2.79%
Spectrum Pharmaceu… CAPS Rating: ***
NBIX $45.06 Down -0.59 -1.29%
Neurocrine Bioscie… CAPS Rating: ***